YAKUGAI Ombudsperson "Medwatcher Japan" is the private medical supply supervisory system.
2022-11-21
On November 21st, 2022, Medwatcher Japan submitted an opinion "We oppose the emergency approval of Shionogi's COVID-19 drug Xocoba" to the Minister of Health, Labor and Welfare.
The full text is in the attached document below.
YAKUGAI Ombudsperson "Medwatcher Japan" Tie-up group
160-0022 Tokyo Shinjuku Ward Shinjuku 1-14-4 AM building
TEL : 03（3350）0607 FAX : 03（5363）7080
Mail : info@yakugai.gr.jp
Our members have other regular jobs and volunteer their services free of charge. Our secretariat also serves as part-time basis, and we are currently in the process of facilitating the secretariat function. Therefore, please note that due to limited resources, we might not be able to respond to each inquiry on specific medicine. Thank you for your understanding.
